NASDAQ:PRAN
Delisted
Prana Biotechnology Ltd Stock Company Profile
$0.86
+0 (+0%)
At Close: Aug 17, 2022
Information
369 Royal Parade
Parkville VIC 3052
61 3 9349 4906
Industry: Biotechnology
Sector: Healthcare
Description
Prana Biotechnology Limited develops therapies for the treatment of Alzheimer's disease, Huntington disease, and other neurodegenerative disorders in Australia. Its lead drug candidates include PBT2 for the treatment of Alzheimers and Huntingtons diseases; and PBT434 for the treatment of Parkinsonian movement disorders. The company is also developing PBT519 for the treatment of brain cancer. It also has a library of approximately 1000 metal protein attenuating compounds. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.
